Sentrx Launches CROplus, Solution provides comprehensive channel partner support for CROs

Little Falls, NJ  - Sentrx, the leading provider of drug safety services to the life science industry, announced today it is launching CROplus, a comprehensive channel partner solution for growth oriented clinical research organizations.  The solution was first discussed at the 19th Annual Partnerships in Clinical Trials Conference in Orlando, FL. 

 “Sentrx received excellent feedback at Partnerships,” said Charles T. Saldarini, CEO of Sentrx. “It is clear the needs sponsor organizations have to seamlessly integrate pharmacovigilance with global clinical development is producing new opportunities for CROs.  Our channel partner solution provides an easy to use set of PV capabilities, knowledge and expertise for CROs who want to capitalize on this fast moving market.”

CROplus addresses four critical areas CROs have targeted in a PV channel partner.  These are custom adverse event management, high speed drug safety implementation, embedded safety technology expertise and flexible client management reporting.  Accordingly, Sentrx has organized its CROplus solution to include: 

  • Highly configurable adverse event management services, enabling CROs to customize workflow, support global regulatory reporting and integrate both proprietary and 3rd party signal detection tools;
  • Fully integrated PV implementation plans, including pre-qualification audit support, SOP development and systems assessment;
  • Flexible client reporting packages selected from basic production metrics, Sentrx insights and observations and Sentrx signaling and trending;
  • World class safety technology expertise for fast, efficient installation of “case ready” safety systems accessible by global resources 24/7/365

Michael O’Gorman, Chief Financial Officer & Vice President for Strategic Alliances, said “Sentrx CROplus is an enabling solution to connect CROs to the $2B global PV market.  Our commercial solutions team is ready to help CROs develop proposals, assess ROI and establish road maps for additional safety services we’re developing internally and with our business partners Oracle and Phase Forward.”   

Sentrx297access overlay

 

Wade Weinzetl
VP, Safety Systems Technologies

Wade.weinzetl@sentrx.com